tionally, the microvascular pathology observed in developing Ccm1 mutant zebrafish embryos mirrors that seen in human CCM lesions, suggesting that zebrafish might provide a superior animal model to study the pathogenesis of human CCM.
Introduction
In humans, cerebral cavernous malformations (CCMs) are vascular lesions characterized by distended intracranial capillaries with a thin layer of vascular endothelial cells (VECs). This vasculature lacks supportive parenchyma, compromising vascular integrity and thus potentially causing hemorrhage and stroke. Hereditary CCM has been found to be caused by a loss-of-function mutation in one of three CCM genes: KRIT1 (CCM1), MGC4607 (CCM2), and PDCD10 (CCM3). On the molecular level, CCM1 interacts with integrin cytoplasmic domain-associated protein-1 ␣ (ICAP1 ␣ ), suggesting a role in ␤ 1 -integrin-mediated signaling [1] [2] [3] . Researchers have established that all three CCM gene products interact with each other and form a CCM complex [4] [5] [6] [7] that modulates signal transduction pathways [3, 8, 9] . While the precise pathophysiology connecting the CCM protein complex to microvascular malformation has remained elusive, the critical importance of the complex is evidenced by the observation that at least one of its components is disrupted in most human CCMs. Therefore, much attention has recently been directed toward the roles played by the CCM complex in vasculogenesis and/ or angiogenesis.
In contrast to humans, defects in major blood vessels and the heart have been detailed in Ccm animal models [10] [11] [12] . Enlarged heart chambers and large blood vessel changes have been described in Ccm1 (santa, san) and Ccm2 (valentine , vtn) mutant zebrafish lines, respectively [10] [11] [12] [13] . It has been postulated that both Ccm1 and Ccm2 regulate the concentric growth of myocardium without changing the fate of cardiomyocytes or endothelial cells [12] . In mice, Ccm1 knockout has been reported to induce dilation of heart chambers and large arteries (such as the aorta) and to preferentially narrow certain arteries, leading to the hypothesis that Ccm1 is essential for vasculogenesis, the de novo formation of the blood vessel backbone. Unlike previous zebrafish studies, associated heart defects in mice have been presumed secondary to vascular malformation [14] . Two recent studies in zebrafish embryos posit that Ccm1 and Ccm2 mutations cause the dilation of major vessels (especially primitive veins) and the progressive thinning of endothelial cells lining these primitive vessels, suggesting that Ccm1 proteins regulate VEC genesis, particularly vascular tubule formation during vasculogenesis, and supporting the previous perturbed vasculogenesis hypothesis in mouse models [13] [14] [15] . Two recent studies in mice and zebrafish further emphasized defective endothelial association and barrier function, or excessive dysfunctional sprouting which leads to vessel enlargement in the primitive vessels of Ccm2 mutants [16, 17] .
This study advances prior research on CCM in several ways. First, by studying san zebrafish lacking Ccm1, we have established a critical role for Ccm1 in the promotion of angiogenesis and, in contrast to prior reports, have found vasculogenesis and earlier angiogenic events to be unaffected by Ccm1 deficiency. Instead, Ccm1 plays a major role in the regulation of microvascular vacuole formation, fusion, and lumenization during angiogenesis in zebrafish embryonic development. The loss of Ccm1 induces defective microvascular angiogenesis by disrupting microvascular lumenization. Importantly, the defective lumenization was not caused by a loss of blood flow but by the inability of VECs to form vacuoles and hence lumens. This microvascular pathology in zebrafish mirrors the pathogenesis of human CCM lesions, in which lumenless capillaries (termed collapsed vessels) are intertwined with lumen-enlarged capillaries (termed dilated vessels or cavities). As such, Ccm1 mutant zebrafish provides an excellent model to study the pathogenesis of CCM in humans.
Second, we have elucidated the molecular mechanisms by which CCM1 deficiency results in failed microvascular development. This pathophysiology was investigated using in vitro studies in human umbilical vein endothelial cell (HUVEC) lines. As with zebrafish, the loss of CCM1 disrupts vascular lumenization in HUVECs. The absence of CCM1 inhibits the activation of Rac-1 small G protein, a key molecule that regulates the induction of vacuole formation, fusion, and lumenization in VECs.
Materials and Methods

Zebrafish Care
Zebrafish lines used in this experiment were purchased from the Zebrafish International Resource Center (Eugene, Oreg., USA). Zebrafish maintenance was performed according to the established Kimmel protocol [18] . A double transgenic line was created by crossing a Ccm1 mutant strain (KRIT1 ty219c/+(AB) ) with a Tg(fli1:EGFP) y1/+(AB) strain in which the robust expression of EGFP in vascular endothelium enabled us to perform sensitive time-lapse microscopic imaging of blood vessels in developing embryos in vivo. Ccm1 mutant (CCM1 -/-) zebrafish (santa , san) with Tg(fli1:EGFP) background were identified by their distinctive phenotype of deficient circulation and enlarged heart chambers, starting 36-48 hpf (hours post fertilization) [10] [11] [12] 19] .
Imaging and Microangiography
Embryos at 24-72 hpf were dechorionated using Watchman's forceps, anesthetized in 0.6% tricaine, and mounted in 0.5% agarose on depression slides. Fluorescent images or time-lapse videos were acquired with a Nikon 90i microscope and a Coolsnap ES CCD camera (Roper Scientific), and processed using Metamorph 6.3 (MDS). After imaging, embryos were recovered by washing with system water, and placed individually into 24-well culture plates to allow them to develop for phenotype checking as described before [19] .
Morpholino Analysis
Antisense oligonucleotide morpholinos (MOs) to Ccm1 gene (MO1 and MO2; GeneTools) were diluted in 1 ! Danieau's buffer to a 0.5-m M concentration as previously described [12, 19] . The injection of MO solution (volumes: 0.1, 0.2, 0.5, 1, and 2 nl) or control buffer was performed on fertilized eggs at 1-cell stage from Tg(fli1:EGFP) zebrafish under AB wild-type background. After injection, the embryos were allowed to develop to designated stages at 28.5 ° C. 
Whole-Mount Immunofluorescent Staining of Zebrafish
Endothelial Cell Culture and RNAi
HUVECs were cultured in EGM2 medium (Clonetics). siRNA duplex targeting human CCM1 (KRIT1) and ICAP1 ␣ RNA were used as previously described [3] . All gene-specific siRNA oligos and commercially available control siRNA duplex SCRAMBLE II and luciferase GL2 duplex were synthesized at Dharmacon, and transfections were carried out with Oligofectamine reagent (Invitrogen) as described by the manufacturer.
Cell Migration and Tube Formation Assay
The cell migration assay was carried out using a multiwell insert system (BD Biosciences). In each well, 15-25 ! 10 3 HUVECs were incubated at 37 ° C in the insert for 16 h. After HUVEC migration through the pores, they were fixed and stained with DiffQuik (Behring). The endothelial cell transwell migration was counted under the microscope. After RNAi treatment, 2 ! 10 4 HUVECs/well were incubated for 12 h at 37 ° C on ECMatrix (in vitro angiogenesis assay kit; Chemicon). Tube formation processes were imaged and analyzed using the branch point counting method (Chemicon).
Antibodies, Immunocytochemistry, and Western Blot
Primary antibodies, AK (C-19), Cdc42 (B-8), and Rac1 (23A8), were purchased from Upstate. For the small GTPase assay, cells were lysed, and equal amounts of lysate samples from each treatment were loaded on SDS-PAGE directly or co-immunoprecipitated with PAK-1 PBD agarose beads (cat. No. 14-325, Upstate). Protein concentrations of the RNAi treatment lysates were measured using the RC DC protein assay (Bio-Rad). Equal amounts of protein from each treatment were then loaded on SDS-PAGE and detected with designated antibodies followed by chemiluminescence (GE).
Statistical Testing
For multiple comparisons, one-way analysis of variance (ANOVA) was used to detect differences in the mean values among all treatment groups. Pairwise comparison (t test) was used to test the difference between each treatment.
Results
Vasculogenesis Is Normal in san Zebrafish Embryos
The backbones of large axial arteries and veins are formed de novo through the migration and coalescence of endothelial precursor cells from mesoderm, a process called vasculogenesis [20, 21] . To observe the effect of loss of Ccm1 function on vasculogenesis in embryonic zebrafish, dynamic fluorescent vasculature images were acquired in vivo from wild-type and Ccm1 mutant (Ccm1 -/-, san) embryos. At 24-26 hpf, a primitive network of axial vessels consisting of dorsal aorta (DA), posterior cardinal vein (PCV), caudal artery (CA), and caudal vein (CV) were observed. From 24 hpf, DA and PCV form distinct lumens and start circulating primitive blood along primitive vessels as they function as shunt. In contrast to previous reports [13, 15] , we observed no significant differences in vasculogenesis between wild-type and san zebrafish embryos. Additionally, the distribution of vasculature, lumenization of large arteries and veins, and aortic structures were comparable in all embryos ( fig. 1 ; online suppl. fig. 1 , video 1; for all online supplementary material, see www.karger.com/doi/10.1159/000316851), affirming that Ccm1 is not required for the primitive axial vessel formation of vasculogenesis.
Sprouting in Primary Angiogenesis Is Unaffected in san Zebrafish Embryos
Two distinct angiogenic events have been temporally defined during embryonic angiogenesis: a primary artery-driven vascular lattice first forms in primary angiogenesis, followed by the emergence and growth of a network of vein-driven sprouts in secondary angiogenesis [20, 21] . The emergence of primary arterial sprouts begins at 20 hpf, a few hours before a patent axial plexus is fully developed (23-24 hpf), and usually spans from 20 to 36 hpf. These sprouts are originated from primitive arteries (DA and CA), and they form rudimentary intersegmental arteries (SeA); SeA will ultimately migrate dorsally, and connect with each other to form new dorsal longitudinal anastomotic vessels (DLAV). The vast majority of SeAs will remain as lumenless cords of VECs until secondary angiogenesis begins.
Our observation indicated that the sprouting of VECs from large arteries (DA and CA) appeared the same in san and wild-type embryos at 24 hpf. At this stage, no lumens were established in the newly established SeA. However, rhythmic beatings of primitive heart tubes and slow blood flow within the large primitive vessels (DA, CA, PCV, and CV) were observed in all wild-type embryos and Ccm1 mutants, as indicated by the vigorous contraction of GFP-illuminated endocardium. We observed no difference in the beating frequency and lumen diameter of the heart, and SeA lattice formation in wildtype and san embryos at this embryonic stage ( fig. 1 ; online suppl. fig. 1 , video 1).
Sprouting in Secondary Angiogenesis Is Uninterrupted in san Zebrafish Embryos
As primary embryonic angiogenesis concludes, secondary angiogenic vessel sprouting starts immediately, lasting from 36 to 72 hpf. Secondary sprouts emerge exclusively from large veins (PCV and CV) to form inter-segmental veins (SeV). Half of SeVs make stochastic connections to the adjacent primary segments (SeAs), linking the primitive veins (PCV and CV) to the primary angiogenic vascular network. The remaining half of SeVs runs dorsally to form the parachordal vessel in the middle of vessel networks. The combination of a SeA and a SeV is called an intersegmental vessel (ISV). By the end of this embryonic stage (72 hpf), two completed angiogenic ISV networks have been formed on each side of the trunk, and stochastically connected SeAs and SeVs have been transformed from cord-like lattices to a fully functioning network of patent vessels [21] .
Imaging revealed that the sprouting of VECs from PCV and CV appeared the same in both san and wildtype embryos throughout the secondary angiogenesis. The formation of the zebrafish secondary vessel networks was identical in Ccm1 mutants and their wild-type siblings at 36 hpf ( fig. 2 a-d 
Microvascular Lumenization Is Perturbed in san Zebrafish Embryos
While the development of the microvascular network was similar in wild-type and san embryos through 72 hpf, the formation of lumens was distinctly different in these two lines. By screening newly developed SeAs right at the end of primary angiogenesis in wild-type and san embryos, we found that, in wild-type zebrafish, all SeAs showed some degree of early lumenization, but only a small percentage of SeAs (7.6 8 2.4%; n = 65 SeAs) fully developed continuously open lumens. The lumenization of SeA started rostrally and proceeded caudally along the vessel plexus. In contrast, no lumen formation was found in SeAs of Ccm1 mutants at the same developmental stage (n = 80 SeAs). The difference in lumen formation at the end of primary angiogenesis is statistically significant (p ! 0.05, t test). Considering the fact that the hemodynamics in primitive vessels at this stage were quite comparable between wild-type and Ccm1 mutant (online suppl. video 1), we concluded that Ccm1 deficiency results in failed lumenization in SeAs during the primary angiogenesis.
From 36 hpf, we observed that the sprouting SeVs started to connect with primary SeAs to form an ISV network in a relatively rapid manner: ISV lumenization and subsequent initiation of circulation started momentarily after SeVs developed ( fig. 2 b) . At this stage, angiogenic vessels, including all ISVs and cranial microvasculature, showed clearly progressive lumenization in wild-type embryos ( fig. 2 a, b) , as these vessels prepared to conduct fast circulation of blood cells. At 48 hpf, nearly all ISVs in wild-type embryos showed lumenization ( fig. 2 e, 3 a-c; online suppl. video 3a), and microangiography data showed full blood circulation in almost half of ISVs of wild-type embryos (online suppl. fig. 2 ). In contrast, neither obvious vessel lumenization nor blood circulation was observed in the angiogenic microvasculature of san embryos at the same embryonic stages ( fig. 2 f-h, 3 d-f , online suppl. fig. 2 ). By 72 hpf, ISVs were completely developed and fully functional in the wild type; in contrast, the only sign of attempted lumenization observed in Ccm1 mutant zebra fish at 72 hpf was funnel-shaped dorsal enlargement and ramification in some ISVs ( fig. 2 j, 3 f, arrowhead), a vessel phenotype identical to the zebrafish mutant Silent heart (sih) . The ventral ends and central sections of the ISVs remained closed cords at 48-72 hpf ( fig. 2 f, h, j) . These findings indicate that the angiogenic lumen formation during angiogenesis is ceased in san embryos ( fig. 2 , 3 ; online suppl. fig. 1 ).
Early Circulation through the Heart and Primitive Vessels Is Unaffected in san Zebrafish Embryos
Circulation in Large Primitive Vessels The earliest circulation of blood cells within primitive vessels (DA, CA, CV, and PCV) starts at 24-26 hpf, followed by circulation in a rostral loop in the head [20] . Previous research has observed the cessation of circulation through large primitive vessels (DA, PCV, CA, and CV) in Ccm1 mutants [12, 13, 15] . However, our research on san embryos found circulation through the heart and in the large primitive vessels at 24-26 hpf is identical to wild-type embryos until 28-36 hpf (online suppl. video 1), when the blood flow in the large vessels slows down significantly until it disappears. Although some mutants still maintain slow circulation via primitive vessels up to 36 hpf, the primitive heart is pumping vigorously and rhythmically (online suppl. video 2).
Cessation of Microcirculation in ISVs in san Zebrafish
The circulation of blood cells within ISV is observed in wild-type zebrafish after 36 hpf. In contrast, no microcirculation was observed in Ccm1 mutant embryos at this stage ( fig. 2-4 ; online suppl. fig. 1, 2, video 2 ).
Defective Microcirculation Followed by Cardiovascular Malformations in san Zebrafish At 28 hpf, the heart of san embryos starts to show signs of defective blood flow [12] . We observed that in san embryos, the flow of blood cells became stagnant within CCV albeit vigorous heart contractions, indicating the initially damaged atrium-ventricle structure. From 32 hpf and beyond, the defective circulation was accompanied with prominently dilated heart and progressive lumen malformation in primitive vessels, as arteries (DA and CA) started to narrow while PCVs started to dilate in Ccm1 mutant embryos. CVs remained as large venous sinus in Ccm1 mutant embryos, while those in wild-type embryos developed into venous plexuses consisting of interconnecting veins with increasing bright EGFP signals. Both the magnitude of heartbeat and the size of the heart chamber of san embryos increased significantly at 36 hpf, indicating the continuation of cardiac dilatation and atrium-ventricle structural destruction. By 48 hpf, the heart chamber of san embryos was dilated tremendously and the atrium-ventricle structure was disrupted. Blood cells had accumulated within heart chambers and large vessels adjacent to the heart such as the common cardinal vein and DA. Consequently, no effective circulation of blood cells was observed in the large vessels from this point on. Microangiography studies at 48 hpf confirmed the absence of blood flow in both large primitive vessels and small cranial vessels of san embryos compared with normal blood flow in those vessels in wild-type embryos (online suppl. fig. 2 ).
Failed Lumen Formation Is due to Dysregulated Vacuole Formation in VECs in san Zebrafish Embryos
Both in vitro and in vivo studies have proven that intracellular vacuole formation is required for VEC lumen formation [22] [23] [24] . These vacuoles coalesce and establish large intracellular and/or intercellular hollow cavities, eventually leading to vascular lumen formation [23] [24] [25] . In in vitro angiogenesis assay, VECs form cords of invading cells during angiogenesis. Vacuoles have been observed in VECs leading the invasion front, indicating vacuole formation might contribute to the directional expansion of VEC tube networks to facilitate both sprouting and lumen formation [26] [27] [28] .
During angiogenesis in wild-type embryos, imaging uncovered that vacuoles were visible in VECs as they contributed to the process of lumen formation. These vacuoles were not visible in the VECs of san embryos. Specifically, upon examination of VECs during primary VEC sprouting at 28 hpf, primitive vacuoles were observed in VECs in wild-type embryos ( fig. 4 a) but not in san zebrafish ( fig. 4 d) . At 36 hpf during secondary angiogenic sprouting, intracellular vacuoles significantly matured and clustered within VECs along ISV ( fig. 4 b) and eventually formed intracellular and/or extracellular hollow cavities in wild-type embryos ( fig. 4 c) but not in Ccm1 mutants ( fig. 4 e) . These findings support the role of Ccm1 in the vacuolization of VECs prior to microvascular lumenization. As such, Ccm1 is a key regulator modulating lumenization during angiogenesis.
MO Knockdown of Ccm1 Protein Disrupts Lumen Formation in Zebrafish Embryos
To further investigate the relationship of Ccm1 deficiency to failed lumenization, we performed a dose-phenotype study of Ccm1 MO knockdown and analyzed its effect on microvascular structure and circulation. It has been known that Sih zebrafish feature a lack of circulation which secondarily induces constriction of large vessels, which might lead to defective lumenization of microvasculature [21] . Considering the presence of defective microvascular lumenization in both san and sih zebrafish lines, the possibility exists that the same mechanism responsible for failed lumenization in sih zebrafish (i.e. a primary lack of circulation) also occurs in san zebrafish. 
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A gradient of Ccm1 MO was injected into wild-type embryos. After secondary angiogenesis at 48 hpf, phenotypes of Ccm1 MO zebrafish vascular systems were classified into three categories (online suppl. fig. 3 ). Phenotype 1 (normal perfusion with patent vasculature) was detected in wild-type embryos. Phenotype 2 (loss of ISV circulation but normal circulation in major primitive vessels, e.g. DA, PCV, CA and CV; online suppl. video 3) was noted in wild-type embryos before 36 hpf or san embryos but not in sih embryos. For this MO phenotype, ISV circulation appeared in all-or-none fashion, no partial phenotype 2 (in which ISV circulation appears normal at the rostral end but gradually deteriorates caudally along the vessel plexus until no circulation in ISV can be seen) could be identified. Phenotype 3 (total loss of circulation with an enlarged heart) was found to be identical to the vascular condition of the san zebrafish at 48 hpf and beyond.
At low MO dosages (0.1-0.2 nl), approximately half of the san embryos had phenotype 1, approximately half exhibited phenotype 2, and a small percentage showed phenotype 3. At medium dosage (0.5 nl), the san embryos were evenly distributed among the three phenotypes. At high dosages (1-2 nl), the majority of the san embryos exhibited phenotype 3 ( table 1 ) .
The phenotypes outlined above, especially the newly defined phenotype 2, indicated that Ccm1 is essential for the lumenization of ISVs and hence the successful establishment of circulation during secondary angiogenesis. With the role of Ccm1 established in zebrafish, we next turned our focus to understanding the mechanisms by which CCM1 promotes lumenization and by which CCM1 absence causes failed lumenization in human endothelial cells.
Depletion of CCM1 Results in Failure to Form VEC Tubes and Decreased Cell Mobility
Silencing of CCM1 Impairs Integrin-Modulated Cell Mobility In addition to vacuole formation, VEC angiogenesis requires endothelial cell proliferation, mobility, and survival, for example. We undertook several in vitro studies using cultured HUVECs to assess whether CCM1 deficiency affects any of these angiogenic variables. We found that silencing of CCM1 with RNAi significantly inhibits endothelial HUVEC migration capacity ( fig. 5 a) , indicating silencing of CCM1 in VECs has a significantly negative impact on cell mobility.
In in vitro angiogenesis assays, we found that the impairment in angiogenesis can be observed visually ( fig. 5 b) and quantified ( fig. 5 c) . It should be noted that our CCM1 RNAi in vitro tube formation assay results are consistent with Cdc42 and Rac1 RNAi data [27] , indicating that CCM1 might share the same signaling pathway with Cdc42 and Rac1 small GTPases which are essential regulators in VEC mobility and vacuole formation.
Silencing of CCM1 Inhibits Rac1 GTPase Activity Cdc42 and Rac1 GTPases have been proven to be required for vacuole and lumen formation [23, 26, 27] . ICAP1 ␣ has been reported to interact with Cdc42 and Rac1, and modulates the activity of these GTPases [28] . The CCM complex not only regulates Rac1 activity through ICAP1 ␣ but also directly interacts with Rac1 [1, 3, 9, 28] .
With in vitro experimentation, silencing of either CCM1 or its cellular effector, ICAP1 ␣ , significantly decreases steady-state abundance of Rac1-GTP, a known positive regulator of cell motility and a key modulator of vacuole and lumen formation ( fig. 5 d) . No obvious changes in Cdc42 activity by silencing CCM1 were observed (data not shown). In combination with previous findings that the CCM complex not only regulates Rac1 activity through ICAP1 ␣ but also directly interacts with Rac1 [1, 3, 9, 28] , our data provide strong evidence that CCM1 is upstream of Rac1 small GTPase and regulates Rac1 activity through ICAP1 ␣ in the angiogenic signaling pathway during vacuole and lumen formation.
Discussion
Using both in vivo animal models and in vitro human VEC lines, we have demonstrated that Ccm1 deficiency causes failed vacuole and lumen formation in angiogenic ISVs through Rac-1 small GTPase signaling. We have also T he distribution of three phenotypes (normal, loss of ISV circulation only, and total loss of circulation and enlarged heart) varies among different dosages of Ccm1 MO treatment at 48 hpf.
determined that previously reported major cardiovascular defects in Ccm1 zebrafish might be secondary to microvascular pathogenesis. This study has established a paradigm that links Ccm1 molecular function to VEC morphogenesis during microvascular angiogenesis.
The morphology changes of large vessels and the heart in san embryos are very possibly caused by increases in contractile pressure in vein and heart but a decrease in arteries. The enlargement in the heart, caused by either failed concentric growth or increases in blood pressure, disturbs atria-ventricle valve function and results in back-feeding of the circulation to the vein. These overall morphological changes deteriorate progressively with time because of the law of Laplace: The larger the vessel radius, the larger the wall tension required to withstand a given internal fluid pressure.
One can argue that the circulation in Ccm1 mutant zebrafish embryos may appear normal during earlier embryonic stages, the inability of the heart in these animals to generate normal pressures may prevent the flow through small-diameter microvessels which could influence lumenization, as occurs in sih zebrafish. Although the obvious cardiac phenotype may not be apparent until 32 hpf, the functional consequences (i.e. defective pressure generation due to cardiac insufficiency) will manifest much earlier. This argument might be solid for the cause of defective ISV lumenization during secondary angiogenesis when circulation is dramatically decreased in Ccm1 zebrafish; however, it could not challenge the observation of the total loss of ISV lumenization during primary angiogenesis in san embryos. Furthermore, in normal embryos, the embryonic development of the cardiovasculature takes place gradually with time, and angiogenesis (and lumenization) of ISV occur not only gradually with time, but also sequentially from rostral to caudal along major primary blood vessels. Therefore in san embryos, if the underlying pathology is primarily caused by lack of perfusion due to defective cardiac growth and pump dysfunction, the failed lumenization of ISV would appear worse toward the caudal end. This is contrary to what we have observed in both Ccm1 mutant and morphant embryos. Actually, the angiogenic lumenization can only be identified in two categories: all or none. Finally, a specific phenotype (phenotype 2) generated from Ccm1 MO embryos shows apparently normal circulation in the large primitive vessels while the ISV circulation is disrupted in an all-or-none fashion. This phenotype further indicates that loss of ISV circulation is not caused solely by potentially changed hemodynamics originating from the heart. Also, after secondary angiogenesis (48 hpf), this phenotype mirrors the wild-type zebrafish embryos prior to the initiation of secondary angiogenesis (36 hpf) and provides evidence that ISV lumenization, a major event of secondary angiogenesis, does not occur in these MO embryos. Therefore, the presence of this phenotype in Ccm1 morphants indicates that the defective lumenization seen in Ccm1 deficiency is independent of circulation changes. In combining defective lumenization during angiogenesis and vacuole formation observation in san embryos, and Ccm1 MO phenotypes, our data lead to the conclusion that the hemodynamic changes in the circulation system in san zebrafish might be the consequence and not the cause of the failed lumenization.
Prior research emphasized the role of Ccm in vasculogenesis and VEC contacts. However, our research has found that the vital function of Ccm1 is angiogenesis, and perturbed angiogenesis is the origin of circulatory failure in Ccm1 deficiency. Specifically, Ccm1 promotes tubulogenesis via the regulation of microvascular lumenization. We demonstrated that defective lumenization might not be caused by a loss of blood flow, but by failure of VEC vacuole and lumen formation. We also provided in vitro evidence that CCM1 deficiency disrupts angiogenic migration and tubulogenesis in cultured HUVECs and inhibits the activation of Rac-1 small GTPase, a key molecule that regulates the induction of vacuole and lumen formation in VECs. It should be noted that secondary angiogenesis in zebrafish starts at 36 hpf. Not coincidently, expression data have demonstrated that Ccm1 mRNA expression occurs in the axial PCV from 28 to 48 hpf in zebrafish embryos [12] , affirming the essential role of Ccm1 in tubulogenesis.
The implications of the similarity between san zebrafish and human CCM microvascular pathology may extend beyond pathogenetic research. We have shown that Ccm1 is a novel and essential angiogenic factor in vertebrate embryonic angiogenesis. Perhaps the most intriguing potential implication of our findings relates to cancer therapy, with the possibility that Ccm1 could serve as a candidate in the future development of angiogenesis-related pharmaceuticals.
